Shepherd Kaplan Krochuk’s PDL BioPharma, Inc. PDLI Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-177,533	Closed	-$595K	–	402
2016 Q3	$595K	Buy	+177,533	New	+$564K	0.12%	108
2015 Q4	–	Sell	-43,133	Closed	-$217K	–	481
2015 Q3	$217K	Buy	+43,133	New	+$247K	0.06%	250
2014 Q4	–	Sell	-31,512	Closed	-$236K	–	624
2014 Q3	$236K	Buy	+31,512	New	+$293K	0.03%	408
2014 Q1	–	Sell	-29,135	Closed	-$246K	–	700
2013 Q4	$246K	Buy	+29,135	New	+$246K	0.03%	381

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Shepherd Kaplan Krochuk's PDLI Position: Q4 2016 in Review

Shepherd Kaplan Krochuk sold out of PDL BioPharma, Inc. (PDLI) in Q4 2016, closing a stake of 177,533 shares — an estimated $595K sold.

Shepherd Kaplan Krochuk first reported a position in PDLI in Q4 2013 and held it in 4 quarters. The position peaked at $595K in Q3 2016. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

Shepherd Kaplan Krochuk reported no remaining PDL BioPharma, Inc. position as of Q4 2016 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 177,533 PDL BioPharma, Inc. shares in Q4 2016, an estimated $595K.
Shepherd Kaplan Krochuk first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 4 quarters.
Shepherd Kaplan Krochuk's PDL BioPharma, Inc. position peaked at $595K in Q3 2016.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2016, filed 10 Feb 2017.